Pulmonary Rehabilitation in Patients Recovering from COVID-19

Author:

Zampogna Elisabetta,Paneroni Mara,Belli Stefano,Aliani Maria,Gandolfo Alessandra,Visca Dina,Bellanti Maria Teresa,Ambrosino Nicolino,Vitacca MicheleORCID

Abstract

<b><i>Background:</i></b> In hospitalized patients recovering from the SARS-coronavirus-2 disease 19 (COVID-19), high prevalence of muscle weakness and physical performance impairment has been observed. <b><i>Objectives:</i></b> The aim of this study was to evaluate the effectiveness of pulmonary rehabilitation in these subjects in a real-life setting. <b><i>Methods:</i></b> Retrospective data analysis of patients recovering from COVID-19, including those requiring assisted ventilation or oxygen therapy, consecutively admitted to an in-patient pulmonary rehabilitation program between April 1 and August 15, 2020. Short Physical Performance Battery (SPPB: primary outcome), Barthel Index (BI), and six-min walking distance were assessed as outcome measures. <b><i>Results:</i></b> Data of 140 patients were analyzed. After rehabilitation, patients showed improvements in SPPB {from: (median [IQR]) 0.5 (0–7) to 7 (4–10), <i>p</i> &#x3c; 0.001} and BI (from 55 [30–90] to 95 [65–100], <i>p</i> &#x3c; 0.001), as well as in other assessed outcome measures. The proportion of patients unable at admission to stand, rise from a chair and walk was significantly reduced (<i>p</i> &#x3c; 0.00). <b><i>Conclusions:</i></b> Pulmonary rehabilitation is possible and effective in patients recovering from COVID-19. Our findings may be useful to guide clinicians taking care of patients surviving COVID-19 infection.

Publisher

S. Karger AG

Subject

Pulmonary and Respiratory Medicine

Reference25 articles.

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for disease control and prevention. JAMA. 2020;323(13):1239–42.

2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.

4. Vitacca M, Migliori GB, Spanevello A, Melazzini MG, Ambrosino N; COVID-19 ICS Maugeri IRCCS network, et al. Management and outcomes of post-acute COVID-19 patients in Northern Italy. Eur J Intern Med. 2020;78:159–60.

5. Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–53.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3